Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
1261 Views
eMediNexus 04 February 2022
Molnupiravir is an oral antiviral agent for treating mild to moderate COVID-19 illness in patients at higher risk of developing severe illness. Its effects can be highlighted as-
Source- Prescriber, 2022;33(1):24-26. https://doi.org/10.1002/psb.1963
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}